Mission Bio’s Tapestri Platform Helps Elucidate Resistance Mechanisms to Lung Cancer Drugs in Nature Publication

SOUTH SAN FRANCISCO, Calif.: SOUTH SAN FRANCISCO, Calif., Nov. 23, 2021 /PRNewswire/ -- Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, today announced a publication in Nature led by researchers from Memorial Sloan Kettering Cancer Center (MSK) that could broaden the potential benefits for KRAS G12C inhibitors...

Click to view original post